OPDIVO® (nivolumab)
Nivolumab is used in the treatment of non-small cell lung cancer, kidney cancer, head and neck cancer, melanoma, hodgkin’s disease and liver cancer.
Nivolumab - National Cancer Institute
May Treat: Non-small cell lung cancer · Kidney cancer · Head and neck cancer · Melanoma · Hodgkin’s disease · Liver cancer
Nivolumab (Opdivo) Chemotherapy Drug Information
Brand Names: Opdyta
OPDIVO (nivolumab) Label
Drug Class: Programmed Cell Death 1 (PD-1) Checkpoint Inhibitors (Monoclonal antibody (mAb))
Opdivo: Uses, Dosage, Side Effects & Warnings - Drugs.com
Pregnancy: CONSULT YOUR DOCTOR - Nivolumab is unsafe to use during pregnancy. Please consult your doctor.
Explore Opdivo (Nivolumab) With Images
Lactation: CONSULT YOUR DOCTOR - Nivolumab is probably unsafe to use during lactation.
Nivolumab - Wikipedia
Alcohol: CONSULT YOUR DOCTOR - Interaction with alcohol is not known. Please consult your doctor.
Nivolumab (Opdivo) | Cancer Information | Cancer …
May Treat: Non-small cell lung cancer · Kidney cancer · Head and neck cancer · Melanoma · Hodgkin’s disease · Liver cancer